Organization
Kyushu University
4 clinical trials
9 abstracts
Abstract
Final prespecified overall survival (OS) analysis of CLEAR: 4-year follow-up of lenvatinib plus pembrolizumab (L+P) vs sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC).Org: Memorial Sloan Kettering Cancer Center, Kyushu University, University Hospital Essen, P.A. Herzen Moscow Oncological Research Institute, University of Miami Sylvester Comprehensive Cancer Center,
Abstract
Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis.Org: National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, Disaster Medical Center, Tokyo, Japan, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Japan,
Abstract
Biomarker analyses in patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial.Org: Memorial Sloan Kettering Cancer Center, University of Bari "A. Moro" and Policlinico Consorziale, Kyushu University, Texas Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea,
Abstract
Lenvatinib plus pembrolizumab (L+P) vs sunitinib (S) in advanced renal cell carcinoma (aRCC): Patterns of progression and subsequent therapy in the CLEAR trial.Org: University Hospital Essen, Memorial Sloan Kettering Cancer Center, Tel-Aviv Sourasky Medical Center/Tel-Aviv University, Department of Urology and Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany, Medical University of Vienna,
Clinical trial
An Investigator-initiated, Multicenter, Phase 3, Randomized, Single-blind, Double-dummy, Parallel-group Study of Evaluate the Efficacy and Safety of Edoxaban Versus Warfarin (Vitamin K Antagonist) in Subjects With Chronic Thromboembolic Pulmonary Hypertension Taking Warfarin (Vitamin K Antagonist) at Baseline: KABUKIStatus: Completed, Estimated PCD: 2023-03-30
Clinical trial
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid TumorsStatus: Recruiting, Estimated PCD: 2027-08-25
Clinical trial
DVC1-0101 for Intermittent Claudication Secondary to Peripheral Artery Disease: a Randomized Phase IIb TrialStatus: Active (not recruiting), Estimated PCD: 2021-12-01
Clinical trial
PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of PrematurityStatus: Completed, Estimated PCD: 2022-11-30
Abstract
Associations between early tumor shrinkage (ETS)/depth of response (DpR) and overall and post-progression survivals (OS/PPS) from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.Org: National Cancer Center Hospital East, Kashiwa, Japan, Shizuoka Cancer Center, Nagaizumi, Japan, Kyushu University, University of Nantes Medical School, University Medical Center Utrecht,
Abstract
Prognosis of squamous cell carcinoma of the breast by biological subtypes and the efficacy of radiotherapy: The Japanese Breast Cancer Registry analysis.Org: Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, The University of Tokyo Hospital, Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Kyushu University,
Abstract
Optimal molecular-targeted therapies as first-line treatment for RAS wild-type, right-sided metastatic colorectal cancer from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.Org: Shizuoka Cancer Center, Nagaizumi, Japan, National Cancer Center Hospital East, Kashiwa, Japan, Kyushu University, University of Nantes Medical School Nantes, University Medical Center Utrecht,
Abstract
Primary analysis of a phase II study of atezolizumab plus bevacizumab for TACE-unsuitable patients with tumor burden beyond up-to-seven criteria in intermediate-stage hepatocellular carcinoma: REPLACEMENT study.Org: Kindai University Faculty of Medicine, Osaka-Sayama, Japan, Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Hokkaido, Japan, Musashino Red Cross Hospital, Chiba University, Graduate School of Medicine, The University of Tokyo,
Abstract
ASSOCIATIONS BETWEEN ORGAN INVOLVEMENTS AND GENDER, ALLERGY, AND MALIGNANCY IN 166 PATIENTS WITH IGG4-RELATED DISEASEOrg: Kyoto University Graduate School of Medicine, Kobe University Graduate School of Medicine, Department of Rheumatology and Clinical Immunology, Kobe, Japan, Kansai Electric Power Hospital, Sapporo Medical University Hospital, Sapporo-Shi, Japan, Kansai Medical University Hospital,